Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Plasma levels of the beta chemokine regulated upon activation, normal T cell expressed, and secreted (RANTES) correlate with severe brain injury.
Kimberly Lumpkins; Grant V Bochicchio; Bradley Zagol; Kristian Ulloa; J Marc Simard; Stacey Schaub; Walter Meyer; Thomas Scalea (Profiled Authors: Thomas M Scalea; J Marc Simard)
Division of Clinical Outcomes Research, R. Adams Cowley Shock Trauma Center, Baltimore, Maryland, USA.
The Journal of trauma 2008;64(2):358-61.
BACKGROUND: The expression of the beta chemokine RANTES (regulated upon activation, normal T cell expressed, and secreted) has previously been shown to be elevated after traumatic brain injury (TBI) in animal models, but it was unknown whether the plasma level of RANTES was predictive of TBI in critically injured trauma patients. METHODS: A prospective study was conducted on 108 critically ill trauma patients. Patients were stratified by radiologic diagnosis of TBI. Severe TBI was classified as the presence of diffuse axonal injury, midline shift, or herniation based on admission head computed tomography findings. Serum levels were evaluated at admission and hospital day 7. RANTES was measured using Luminex multiplex assays. RESULTS: Fifty-four patients with and without TBI were compared. Severe TBI was diagnosed in 23 of the 54 TBI patients (43%) and mild/moderate TBI was found in 31 (57%) patients. The mean age of the study population was 43 +/- 20 years with a mean Injury Severity Score of 29 +/- 14. There was no significant difference between groups in age, sex, and Injury Severity Score. At admission, RANTES was significantly higher in patients with severe brain injury than in non-TBI patients (mean 1,339 pg/mL vs. 708 pg/mL, p = 0.046), and there was a trend toward significance when comparing patients with severe versus mild/moderate brain injury (mean 1,339 pg/mL vs. 752 pg/mL, p = 0.069). There was no statistically significant difference on day 7. CONCLUSIONS: RANTES was a significant early marker of severe TBI in critically injured trauma patients, consistent with animal models. Future research on the role of RANTES in the pathogenesis of human TBI is warranted.
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Publications
-
1.
2012Deborah M Stein; Peter F Hu; Hegang H Chen; Shiming Yang; Lynn G Stansbury; Thomas M Scalea
The journal of trauma and acute care surgery 2012;73(2):419-24; discussion 424-5. -
2.
2005Jean K Lim; Jennifer M Burns; Wuyuan Lu; Anthony L DeVico
Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5.
Journal of leukocyte biology 2005;78(2):442-52. -
3.
2006Ravichandran Palaniappan; Shailesh Singh; Udai P Singh; Rajesh Singh; Edwin W Ades; David E Briles; Susan K Hollingshead; Walter Royal; Jacquelyn S Sampson; Jonathan K Stiles; et al.
CCL5 modulates pneumococcal immunity and carriage.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(4):2346-56.
Related Topics
Appears in this Publication
Related Experts
Author of this Publication
-
Internal ExpertsPublications
-
344









-
939









-
80









-
119









-
41









-
59










